BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bettoli V, Join-Lambert O, Nassif A. Antibiotic Treatment of Hidradenitis Suppurativa. Dermatol Clin. 2016;34:81-89. [PMID: 26617361 DOI: 10.1016/j.det.2015.08.013] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
Number Citing Articles
1 Goldburg SR, Strober BE, Payette MJ. Hidradenitis suppurativa: Current and emerging treatments. J Am Acad Dermatol 2020;82:1061-82. [PMID: 31604100 DOI: 10.1016/j.jaad.2019.08.089] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
2 Caposiena Caro RD, Molinelli E, Brisigotti V, Offidani A, Bianchi L. Lymecycline vs. clindamycin plus rifampicin in hidradenitis suppurativa treatment: clinical and ultrasonography evaluation. Clin Exp Dermatol 2021;46:96-102. [PMID: 32683727 DOI: 10.1111/ced.14388] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
3 Damiani G, Leone S, Fajgenbaum K, Bragazzi NL, Pacifico A, Conic RR, Pigatto PD, Maiorana C, Poli P, Berti E, Pace MC, Malagoli P, Bettoli V, Fiore M. Nonalcoholic fatty liver disease prevalence in an Italian cohort of patients with hidradenitis suppurativa: A multi-center retrospective analysis. World J Hepatol 2019;11:391-401. [PMID: 31114643 DOI: 10.4254/wjh.v11.i4.391] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
4 Jørgensen AR, Thomsen SF, Karmisholt KE, Ring HC. Clinical, microbiological, immunological and imaging characteristics of tunnels and fistulas in hidradenitis suppurativa and Crohn's disease. Exp Dermatol 2020;29:118-23. [PMID: 31519056 DOI: 10.1111/exd.14036] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
5 Ring HC, Sigsgaard V, Thorsen J, Fuursted K, Fabricius S, Saunte DM, Jemec GB. The microbiome of tunnels in hidradenitis suppurativa patients. J Eur Acad Dermatol Venereol 2019;33:1775-80. [PMID: 30908704 DOI: 10.1111/jdv.15597] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 11.5] [Reference Citation Analysis]
6 Navrazhina K, Garcet S, Gonzalez J, Grand D, Frew JW, Krueger JG. In-Depth Analysis of the Hidradenitis Suppurativa Serum Proteome Identifies Distinct Inflammatory Subtypes. J Invest Dermatol 2021;141:2197-207. [PMID: 33766512 DOI: 10.1016/j.jid.2021.02.742] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
7 Pereira MN, Matos BN, Gratieri T, Cunha-Filho M, Gelfuso GM. Development and validation of a simple chromatographic method for simultaneous determination of clindamycin phosphate and rifampicin in skin permeation studies. J Pharm Biomed Anal 2018;159:331-40. [PMID: 30025298 DOI: 10.1016/j.jpba.2018.07.007] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
8 Negus D, Ahn C, Huang W. An update on the pathogenesis of hidradenitis suppurativa: implications for therapy. Expert Rev Clin Immunol 2018;14:275-83. [PMID: 29509041 DOI: 10.1080/1744666X.2018.1449647] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 5.7] [Reference Citation Analysis]
9 Solimani F, Meier K, Ghoreschi K. Emerging Topical and Systemic JAK Inhibitors in Dermatology. Front Immunol 2019;10:2847. [PMID: 31849996 DOI: 10.3389/fimmu.2019.02847] [Cited by in Crossref: 52] [Cited by in F6Publishing: 39] [Article Influence: 26.0] [Reference Citation Analysis]
10 Caposiena Caro RD, Cannizzaro MV, Botti E, Di Raimondo C, Di Matteo E, Gaziano R, Bianchi L. Clindamycin versus clindamycin plus rifampicin in hidradenitis suppurativa treatment: Clinical and ultrasound observations. Journal of the American Academy of Dermatology 2019;80:1314-21. [DOI: 10.1016/j.jaad.2018.11.035] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 12.0] [Reference Citation Analysis]
11 Ring HC, Bay L, Nilsson M, Kallenbach K, Miller IM, Saunte DM, Bjarnsholt T, Tolker-Nielsen T, Jemec GB. Bacterial biofilm in chronic lesions of hidradenitis suppurativa. Br J Dermatol 2017;176:993-1000. [PMID: 27564400 DOI: 10.1111/bjd.15007] [Cited by in Crossref: 57] [Cited by in F6Publishing: 40] [Article Influence: 14.3] [Reference Citation Analysis]
12 Bettoli V, Manfredini M, Massoli L, Carillo C, Barozzi A, Amendolagine G, Ruina G, Musmeci D, Libanore M, Curtolo A, Mantovani L, Contini C, Pellacani G, Corazza M. Rates of antibiotic resistance/sensitivity in bacterial cultures of hidradenitis suppurativa patients. J Eur Acad Dermatol Venereol 2019;33:930-6. [PMID: 30394587 DOI: 10.1111/jdv.15332] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 8.0] [Reference Citation Analysis]
13 Smith MK, Nicholson CL, Parks-Miller A, Hamzavi IH. Hidradenitis suppurativa: an update on connecting the tracts. F1000Res. 2017;6:1272. [PMID: 28794864 DOI: 10.12688/f1000research.11337.1] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 7.3] [Reference Citation Analysis]
14 Falola RA, Defazio MV, Anghel EL, Mitnick CDB, Attinger CE, Evans KK. What Heals Hidradenitis Suppurativa: Surgery, Immunosuppression, or Both? Plastic and Reconstructive Surgery 2016;138:219S-29S. [DOI: 10.1097/prs.0000000000002671] [Cited by in Crossref: 16] [Cited by in F6Publishing: 4] [Article Influence: 3.2] [Reference Citation Analysis]
15 Sabat R, Jemec GBE, Matusiak Ł, Kimball AB, Prens E, Wolk K. Hidradenitis suppurativa. Nat Rev Dis Primers 2020;6:18. [PMID: 32165620 DOI: 10.1038/s41572-020-0149-1] [Cited by in Crossref: 56] [Cited by in F6Publishing: 43] [Article Influence: 56.0] [Reference Citation Analysis]
16 Hambly R, Kirby B. Prolonged clindamycin and rifampicin for hidradenitis suppurativa: resist to prevent resistance. Br J Dermatol 2019;180:702-3. [DOI: 10.1111/bjd.17615] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
17 El-Nekeety AA, Salman AS, Hathout AS, Sabry BA, Abdel-Aziem SH, Hassan NS, Abdel-Wahhab MA. Evaluation of the bioactive extract of actinomyces isolated from the Egyptian environment against aflatoxin B1-induce cytotoxicity, genotoxicity and oxidative stress in the liver of rats. Food Chem Toxicol 2017;105:241-55. [PMID: 28442411 DOI: 10.1016/j.fct.2017.04.024] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
18 Alikhan A, Sayed C, Alavi A, Alhusayen R, Brassard A, Burkhart C, Crowell K, Eisen DB, Gottlieb AB, Hamzavi I, Hazen PG, Jaleel T, Kimball AB, Kirby J, Lowes MA, Micheletti R, Miller A, Naik HB, Orgill D, Poulin Y. North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations. Journal of the American Academy of Dermatology 2019;81:91-101. [DOI: 10.1016/j.jaad.2019.02.068] [Cited by in Crossref: 58] [Cited by in F6Publishing: 43] [Article Influence: 29.0] [Reference Citation Analysis]
19 Fania L, Clemente A, Sampogna F, Mazzanti C, Pallotta S, Panebianco A, Sordi D, Caggiati A, Cassotta G, Tiezzi A, Cristiano L, Zecchi V, Napolitano M, Abeni D. Intralesional ultrasound‐guided combined treatment with triamcinolone plus lincomycin in hidradenitis suppurativa: A pilot study. Dermatologic Therapy 2020;33. [DOI: 10.1111/dth.13901] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]